The Food and Drug Administration approved a groundbreaking new oral drug for pancreatic patients suffering from the most aggressive form of the disease. Daraxonrasib, which targets a mutation in a gene called KRAS, doubled the survival time in patients who participated in the trial.
Nbc News
Original source
nbc news app
Check live status on DownRightNow
Dr. Mike predicts the U.S. will lose our measles eradication status this year. He tells me he believes doctors need to bring parents who haven't vaccinated their kids "in closer, allow them to see that we're interested in their children's health and their well-being."
Sanford Health and North Memorial Health announced Tuesday that they completed the merger.
The quarterback knows that recuperation is as important as your training regime. Here’s how he does it.
Special campaign for elimination of measles and rubella in city to begin from Sept 1
Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.
Read Disclaimer